APA (7th ed.) Citation

MT, O., PB, G., CJ, S., C, B., AS, G., & EL, N. (2025). The Successful Use of Upadacitinib as Monotherapy for Hidradenitis Suppurativa and Ulcerative Colitis in the Setting of Refractory Disease. Pediatric dermatology, 42(2), 353. https://doi.org/10.1111/pde.15759

Chicago Style (17th ed.) Citation

MT, Ok, Googe PB, Sayed CJ, Burkhart C, Gulati AS, and Nieman EL. "The Successful Use of Upadacitinib as Monotherapy for Hidradenitis Suppurativa and Ulcerative Colitis in the Setting of Refractory Disease." Pediatric Dermatology 42, no. 2 (2025): 353. https://doi.org/10.1111/pde.15759.

MLA (9th ed.) Citation

MT, Ok, et al. "The Successful Use of Upadacitinib as Monotherapy for Hidradenitis Suppurativa and Ulcerative Colitis in the Setting of Refractory Disease." Pediatric Dermatology, vol. 42, no. 2, 2025, p. 353, https://doi.org/10.1111/pde.15759.